3 M&A Stories to Watch Today

Bristol-Myers Squibb should be able to close its deal with Celgene now

Aug 26, 2019 at 10:28 AM
facebook twitter linkedin

Digesting this morning's market headlines, there are three M&A stories traders should be following. For starters, Bristol-Myers Squibb Co (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) are both making strong moves higher, thanks to news Amgen Inc (NASDAQ:AMGN) is buying CELG's psoriasis drug Otezla for $13.4 billion, paving the way for BMY and CELG's buyout deal. BMY is up 3.1% at $48.04, and CELG shares have added 3.1%, last seen at $96.94.

Meanwhile, Pitney Bowes Inc. (NYSE:PBI) is trading 5.3% higher at $3.80, after the company said it's selling its software solutions business for $700 million. The shipping company's stock has been destroyed in the past year, falling from the $8 area a year ago and touching its lowest point since the early 1980s earlier this month.

The last name to mention here is PDC Energy Inc (NASDAQ:PDCE), which is buying SRC Energy (SRCI) for $971 million in stock. Analysts at Williams Capital weighed in and said the transaction is "logical." PDCE shares are up 16.6% this morning at $29.44, though this still leaves them down 45% in the past year.


If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial


Special Offers from Schaeffer's Trading Partners